292 related articles for article (PubMed ID: 15280156)
1. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
[TBL] [Abstract][Full Text] [Related]
2. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
Li S; Gokden N; Okusa MD; Bhatt R; Portilla D
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F469-80. PubMed ID: 15814532
[TBL] [Abstract][Full Text] [Related]
4. Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu KK; Bhatt R; Kaushal GP; Portilla D
Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney.
Sheikh-Hamad D; Cacini W; Buckley AR; Isaac J; Truong LD; Tsao CC; Kishore BK
Arch Toxicol; 2004 Mar; 78(3):147-55. PubMed ID: 14551673
[TBL] [Abstract][Full Text] [Related]
6. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
[TBL] [Abstract][Full Text] [Related]
7. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
Ramesh G; Reeves WB
Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.
Lin H; Hou CC; Cheng CF; Chiu TH; Hsu YH; Sue YM; Chen TH; Hou HH; Chao YC; Cheng TH; Chen CH
Mol Pharmacol; 2007 Nov; 72(5):1238-45. PubMed ID: 17671096
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
[TBL] [Abstract][Full Text] [Related]
12. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic study of cisplatin-induced nephrotoxicity.
Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells.
Ramesh G; Brian Reeves W
Ren Fail; 2006; 28(7):583-92. PubMed ID: 17050242
[TBL] [Abstract][Full Text] [Related]
15. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
Sugden MC; Bulmer K; Gibbons GF; Holness MJ
Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
[TBL] [Abstract][Full Text] [Related]
16. Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice.
Yin X; Apostolov EO; Shah SV; Wang X; Bogdanov KV; Buzder T; Stewart AG; Basnakian AG
J Am Soc Nephrol; 2007 Sep; 18(9):2544-53. PubMed ID: 17675668
[TBL] [Abstract][Full Text] [Related]
17. Blocking tumor necrosis factor-alpha inhibits folic acid-induced acute renal failure.
Wan B; Hao L; Qiu Y; Sun Z; Cao Q; Zhang Y; Zhu T; Wang H; Zhang Y
Exp Mol Pathol; 2006 Dec; 81(3):211-6. PubMed ID: 16595132
[TBL] [Abstract][Full Text] [Related]
18. Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury.
Xie J; Guo Q
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F107-15. PubMed ID: 16896190
[TBL] [Abstract][Full Text] [Related]
19. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Cuzzocrea S
Immunology; 2006 Aug; 118(4):559-70. PubMed ID: 16764691
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
